Research Topics in Medicines and How Our Board Members Are Engaged in Them

With the development of analytical instruments, the academic system has become more complicated, producing new journals one after another. Therefore, it became much important to clarify what is original of “Medicines”. As the name Medicines indicates, it includes science and practice of caring for a...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2022
Language:English
Physical Description:1 electronic resource (480 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 06713nam-a2201933z--4500
001 993544459204498
005 20231214132815.0
006 m o d
007 cr|mn|---annan
008 202206s2022 xx |||||o ||| 0|eng d
035 |a (CKB)5720000000008430 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/84594 
035 |a (EXLCZ)995720000000008430 
041 0 |a eng 
100 1 |a Sakagami, Hiroshi  |4 edt 
245 1 0 |a Research Topics in Medicines and How Our Board Members Are Engaged in Them 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (480 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a With the development of analytical instruments, the academic system has become more complicated, producing new journals one after another. Therefore, it became much important to clarify what is original of “Medicines”. As the name Medicines indicates, it includes science and practice of caring for a patient and managing the diagnosis, prognosis, prevention, treatment or palliation of their injury or disease. Therefore, Medicines differs from other journals with similar title in that it covers a wide range of fields, from traditional medicine to rapidly developing molecular-targeted drugs, focusing on their pharmacological effects, structure–activity relationships, metabolic pathways, gene expression, using cultured cells, animals, and clinical trials. Most parts of this Special Issue were written by our editorial board members, who described the research topics and how they are engaged in their field of research. All of these articles are their life-long story. We collected a total number of 22 original works by basic researchers and clinical doctors. We hope that readers can get a chance to know the current status of diverse fields of medicines, and what your most important research themes are after reading these articles. 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a Hedychium 
653 |a traditional medicine 
653 |a coronarin D 
653 |a villosin 
653 |a anti-acetylcholinesterase 
653 |a antidiabetic 
653 |a anti-inflammatory 
653 |a antimicrobial 
653 |a antioxidant 
653 |a antitumor 
653 |a Genista tridentata 
653 |a Pterospartum tridentatum 
653 |a isoflavones 
653 |a flavonols 
653 |a genistein 
653 |a biochanin A 
653 |a rutin 
653 |a daidzein 
653 |a inflammatory bowel disease 
653 |a Crohn’s disease 
653 |a ulcerative colitis 
653 |a extra-intestinal manifestations 
653 |a orofacial granulomatosis 
653 |a tag-like lesions 
653 |a cobblestoning 
653 |a mucogingivitis 
653 |a lip swelling 
653 |a aphthous stomatitis 
653 |a Angelicae Sinensis Radix 
653 |a Danggui 
653 |a granules 
653 |a herb 
653 |a multivariate analysis 
653 |a ultra-performance liquid chromatography 
653 |a Tai Chi 
653 |a qigong 
653 |a immune system 
653 |a immunity 
653 |a inflammation 
653 |a telemedicine 
653 |a remote monitoring 
653 |a GER-e-TEC 
653 |a elderly patient 
653 |a artificial intelligence 
653 |a geriatric syndromes 
653 |a detection of the precursory signs of decompensation of geriatric syndromes 
653 |a renal cell cancer 
653 |a genomic landscape 
653 |a targeted therapy 
653 |a tumor evolution 
653 |a tumor heterogeneity 
653 |a allergic rhinitis 
653 |a quercetin 
653 |a human CD4+ T cells 
653 |a Th1/Th2 cytokine balance 
653 |a modulation 
653 |a in vitro 
653 |a intravascular catheter 
653 |a CRBSI 
653 |a biofilm 
653 |a CVC 
653 |a antifouling 
653 |a chromone 
653 |a tumor specificity 
653 |a QSAR analysis 
653 |a apoptosis 
653 |a cell cycle analysis 
653 |a contrast-enhanced ultrasound 
653 |a hepatocellular carcinoma 
653 |a LI-RADS 
653 |a chronic liver disease 
653 |a granuloma annulare 
653 |a granulomatous disorders of the skin 
653 |a inflammatory skin conditions 
653 |a medical dermatology 
653 |a biliary tract cancer 
653 |a cholangiocarcinoma 
653 |a PARP 
653 |a BRCA 
653 |a olaparib 
653 |a rucaparib 
653 |a liver cancer 
653 |a pancreatic adenocarcinoma 
653 |a pancreatic cancer 
653 |a sarcoidosis 
653 |a superior vena cava syndrome 
653 |a venous thrombosis 
653 |a RUCAM 
653 |a Roussel Uclaf Causality Assessment Method 
653 |a diagnostic algorithm 
653 |a iDILI 
653 |a iDrug induced liver injury 
653 |a DILI 
653 |a HILI 
653 |a herb induced liver injury 
653 |a Stachys L. 
653 |a traditional uses 
653 |a pharmacological activities 
653 |a phytochemicals 
653 |a bioactive compounds 
653 |a Kampo formulae 
653 |a alkaline extract of Sasa sp. 
653 |a pine cone extract 
653 |a povidone-iodine 
653 |a HSV 
653 |a HIV 
653 |a loss of infectivity 
653 |a solubilization method 
653 |a diaphragmatic breathing 
653 |a abdominal breathing 
653 |a breathing exercise 
653 |a systematic review 
653 |a randomized controlled trial 
653 |a respiratory function 
653 |a auricular acupuncture 
653 |a preoperative anxiety 
653 |a protocol 
653 |a randomized controlled trials 
653 |a meta-analysis 
653 |a boiogito 
653 |a knee osteoarthritis 
653 |a rat 
653 |a Yokukansan 
653 |a fentanyl 
653 |a transient receptor potential ankyrin 1 (TRPA1) channel 
653 |a phosphorylated extracellular signal-regulated kinase (pERK) 
653 |a whole-cell patch-clamp recording 
653 |a herbal medicine 
653 |a calcium metabolism 
653 |a bone metabolism 
653 |a protease 
653 |a osteoclast 
653 |a macrophage 
653 |a RANKL 
653 |a LPS 
653 |a TLR4 
653 |a TREM2 
776 |z 3-0365-3685-X 
776 |z 3-0365-3686-8 
700 1 |a Sakagami, Hiroshi  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:31:04 Europe/Vienna  |f system  |c marc21  |a 2022-07-02 22:45:44 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337630290004498&Force_direct=true  |Z 5337630290004498  |b Available  |8 5337630290004498